Search

Your search keyword '"Geissler, Jan"' showing total 274 results

Search Constraints

Start Over You searched for: Author "Geissler, Jan" Remove constraint Author: "Geissler, Jan"
274 results on '"Geissler, Jan"'

Search Results

7. An inter-specialty cancer training programme curriculum for Europe

8. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures

9. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

11. Delivering precision oncology to patients with cancer

12. Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools

13. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

15. Patient authorship of medical research publications: An evolution, revolution, and solution?

16. Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)

18. The European Code of Cancer Practice

22. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

24. Role of Patient Organisations

25. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures

26. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting

28. Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97)

29. The European Cancer Patient’s Bill of Rights, update and implementation 2016

30. Efficacy and Safety Results from ASC4MORE, a Randomized Study of Asciminib (ASC) Add-on to Imatinib (IMA), Continued IMA, or Switch to Nilotinib (NIL) in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Not Achieving Deep Molecular Responses (DMRs) with ≥1 Year of IMA

32. Pan-Stakeholder Core Outcome Set (COS) Definition for Hematological Malignancies within the Framework of Harmony and Harmony PLUS Projects

35. Mobile Music

42. Materia medica (Arzneimittelbilder)

47. Abstract 4094: WAYFIND-R: Delivering a high-quality real-world data (RWD) global registry of patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS)

48. Abstract 5246: Conceptualization of core clinico-molecular variables for registries enrolling patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS)

50. Delivering affordable cancer care in high-income countries

Catalog

Books, media, physical & digital resources